Madbouly, Neveen’s team published research in Journal of Medical Microbiology in 2021 | CAS: 55981-09-4

Journal of Medical Microbiology published new progress about Cryptosporidiosis. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, Formula: C12H9N3O5S.

Madbouly, Neveen published the artcileThe immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model, Formula: C12H9N3O5S, the main research area is nitazoxanide secnidazole immunomodulatory agent Cryptosporidium; C. parvum; immunomodulation; nitazoxanide; secnidazole.

Cryptosporidium parvum causes intestinal parasitic infections affcting both immunosuppressed and immuno competent individuals. Given the absence of effctive treatments for cryptosporidiosis, especially in immunodeficient patients, the present study was designed to assess the therapeutic efficy of secnidazole (SEC) and its combination with nitazoxanide (NTZ) in comparison to single NTZ treatment in relation to the immune status of a murine model of C. parvum infection. The infected groups were administered NTZ, SEC or NTZ-SEC for three or five successive doses. At days 10 and 12 post-infection (p.i.), the mice were sacrified, and the efficy of the applied drugs was evaluated by comparing the histo pathol. alterations in ileum and measuring the T helper Th1 (interferon gamma; IFN-γ), Th2 [interleukin (IL)-4 and IL-10] and Th17 (IL-17) cytokine profies in serum. The NTZ-SEC combination recorded the maximal reduction of C. parvum oocyst shedding, endogenous stages count and intestinal histopathol., regardless of the immune status of the infected mice. The efficy of NTZ-SEC was dependent on the period of administration, as the 5 day-based treatment protocol was also more effctive than the 3 day-based one in terms of immunocompetence and immunosuppression. The present treatment schedule induced an immunomodulatory effect from SEC that developed a protective immune response against C. parvum infection with reduced production of serum IL-17, IFN-γ, IL-4 and IL-10. Application of NTZ-SEC combined therapy may be useful in treatment of C. parvum, especially in cases involving immunosuppression.

Journal of Medical Microbiology published new progress about Cryptosporidiosis. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, Formula: C12H9N3O5S.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics